Inventor · disambiguated record
Bradley Henkle
Also filed as: HENKLE BRADLEY
4 granted patents·8 pending applications·48 citations·filing 2017–2024
77Inventor score
Top patents by PatentIndex Score
12 records- 0197US10322174B2Neutralizing anti-TL1A monoclonal antibodiesCEDARS SINAI MEDICAL CENTER·Filed 2017·Granted Jun 18, 2019·25 cites·7 claims
- 0295US11440954B2Optimized anti-TL1A antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2020·Granted Sep 13, 2022·7 cites·20 claims
- 0395US11292848B2Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2020·Granted Apr 5, 2022·14 cites·20 claims
- 0492US11999789B2Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2022·Granted Jun 4, 2024·2 cites·7 claims
- 0585US2024368263A1Optimized anti-tl1a antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0678US2023192835A1Optimized anti-tl1a antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0778US2023381308A1Neutralizing anti-tl1a monoclonal antibodiesCEDARS SINAI MEDICAL CENTER·Filed 2023·Application pending·0 cites
- 0878US2024327532A1Humanized antibodies to tnf-like ligand 1a (tl1a) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0969US2021093718A1Neutralizing anti-tl1a monoclonal antibodiesCEDARS SINAI MEDICAL CENTER·Filed 2020·Application pending·0 cites
- 1067US2019247498A1Neutralizing anti-tl1a monoclonal antibodiesCEDARS SINAI MEDICAL CENTER·Filed 2019·Application pending·0 cites
- 1156US2024336691A1Anti-tl1a antibody compositions and methods of treatment in the lungPROMETHEUS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1254US2024309104A1Compositions comprising humanized antibodies to tnf-like ligand 1a (tl1a) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →